V. Fleury

448 total citations
7 papers, 366 citations indexed

About

V. Fleury is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Hematology. According to data from OpenAlex, V. Fleury has authored 7 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 4 papers in Hematology. Recurrent topics in V. Fleury's work include Blood properties and coagulation (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). V. Fleury is often cited by papers focused on Blood properties and coagulation (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). V. Fleury collaborates with scholars based in France, Belgium and United States. V. Fleury's co-authors include Eduardo Anglés‐Cano, Marlys L. Koschinsky, Didier Rouy, John Chapman, H.R. Lijnen, H.R. Lijnen, Stéphane Loyau, W. Nieuwenhuizen, Victor Gurewich and Donogh P. O'Brien and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

V. Fleury

7 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Fleury France 6 222 160 108 93 69 7 366
F Fauvel France 11 70 0.3× 195 1.2× 63 0.6× 75 0.8× 42 0.6× 23 343
P. Łoś Netherlands 11 187 0.8× 160 1.0× 83 0.8× 102 1.1× 42 0.6× 18 346
I. Vanlinthout Belgium 10 154 0.7× 153 1.0× 90 0.8× 97 1.0× 29 0.4× 17 363
Wight Tn United States 7 50 0.2× 115 0.7× 26 0.2× 129 1.4× 38 0.6× 11 335
Stephen Wu United States 8 40 0.2× 270 1.7× 80 0.7× 164 1.8× 47 0.7× 10 482
Franziska Leonhardt Germany 10 93 0.4× 105 0.7× 24 0.2× 145 1.6× 45 0.7× 13 385
Michel Monteau France 7 149 0.7× 37 0.2× 88 0.8× 84 0.9× 48 0.7× 11 335
Susanna Teppo Finland 11 139 0.6× 69 0.4× 23 0.2× 237 2.5× 29 0.4× 16 419
JP Rosa France 9 36 0.2× 469 2.9× 134 1.2× 143 1.5× 100 1.4× 14 650
RC Johnson United States 3 49 0.2× 145 0.9× 19 0.2× 68 0.7× 26 0.4× 4 335

Countries citing papers authored by V. Fleury

Since Specialization
Citations

This map shows the geographic impact of V. Fleury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Fleury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Fleury more than expected).

Fields of papers citing papers by V. Fleury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Fleury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Fleury. The network helps show where V. Fleury may publish in the future.

Co-authorship network of co-authors of V. Fleury

This figure shows the co-authorship network connecting the top 25 collaborators of V. Fleury. A scholar is included among the top collaborators of V. Fleury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Fleury. V. Fleury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Jagerschmidt, Alexandre, et al.. (1998). Human thrombopoietin structure–function relationships: identification of functionally important residues. Biochemical Journal. 333(3). 729–734. 11 indexed citations
2.
Soria, J., H.R. Lijnen, V. Fleury, et al.. (1997). A monoclonal antibody directed against an epitope in the NH2-terminal region of native human plasminogen induces a modification of its functional properties. Fibrinolysis & proteolysis. 11(3). 155–163. 5 indexed citations
3.
Fleury, V., Stéphane Loyau, H.R. Lijnen, W. Nieuwenhuizen, & Eduardo Anglés‐Cano. (1993). Molecular assembly of plasminogen and tissue‐type plasminogen activator on an evolving fibrin surface. European Journal of Biochemistry. 216(2). 549–556. 41 indexed citations
4.
Fleury, V., H.R. Lijnen, & Eduardo Anglés‐Cano. (1993). Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.. Journal of Biological Chemistry. 268(25). 18554–18559. 46 indexed citations
5.
Fleury, V., Victor Gurewich, & Eduardo Anglés‐Cano. (1993). A study of the activation of fibrin-bound plasminogen by tissue-type plasminogen activator, single chain urokinase and sequential combinations of the activators. Fibrinolysis and Proteolysis. 7(2). 87–96. 17 indexed citations
6.
Rouy, Didier, Marlys L. Koschinsky, V. Fleury, John Chapman, & Eduardo Anglés‐Cano. (1992). Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry. 31(27). 6333–6339. 80 indexed citations
7.
Fleury, V. & Eduardo Anglés‐Cano. (1991). Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines. Biochemistry. 30(30). 7630–7638. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026